For the millions of older adults navigating a daily regimen of five, seven, or even ten medications, the risk of harm quietly compounds with each added prescription. Researchers at Mass General Brigham have asked whether artificial intelligence might help untangle this pharmaceutical complexity, testing ChatGPT's capacity to assist in deprescribing decisions for elderly patients. The findings, published in the Journal of Medical Systems, suggest the technology holds genuine promise but carries inconsistencies and blind spots that remind us how much distance remains between a capable tool and a
News-Medical.net
· Apr 18, 2024
· health
· 2 min de leitura
High
Apuração: Verificado
ChatGPT Shows Promise in Managing Polypharmacy for Older Adults
Polypharmacy in older adults increases risk of adverse drug interactions and medication-related harm, affecting millions of seniors.
◉
Technology
8572 artigos relacionados
Google Pixel 11 Pro Fold launches with Tensor G6, Gemini AI, and new O…
Business Today · 100% correspondência
Honor's Robot Phone and Google Pixel 11 Lead Week's Tech Innovation Ra…
Google News · 99% correspondência
Tech Giants Embrace Nuclear Power to Meet Surging AI Energy Demands
CNBC · 99% correspondência
AI's Power Hunger Derails Big Tech's Climate Pledges
Fortune · 99% correspondência
Google to Retire Assistant on Phones, Watches by September 2026
Bangkok Post · 99% correspondência
Cobertura Relacionada
CBS News · Aug 21
Meta Smart Glasses Fuel Privacy Crisis as Covert Filming Trend Spreads
A woman was secretly filmed by someone wearing Meta's AI smart glasses in a viral prank video, raising concerns about we…
CBS News · Aug 21 Consumer groups urge FTC probe into AI firms' 'hoard-and-destroy' book practicesConsumer advocacy groups urge the FTC to investigate AI developers for allegedly buying, scanning, and destroying millio…
BBC News · Aug 21 Ofcom investigates Sky News over Farage family privacy claimsOfcom has launched an investigation into Sky News following harassment complaints by Reform UK leader Nigel Farage, who …
Pocket-lint · Aug 21 Amazon's Fire OS 16 Update Bypasses Fire Sticks EntirelyAmazon's new Fire OS 16 update will only launch on smart TVs, not Fire Sticks, as the company transitions all future sti…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
ChatGPT demonstrates potential for managing polypharmacy in elderly patients but exhibits inconsistencies and biases requiring refinement before clinical use.
Escalation Risk
low
Confidence
LOW
Lente Econômica
📈
ChatGPT shows potential for managing polypharmacy in elderly patients but requires refinement due to inconsistencies and biases before clinical implementation.
Market Signal
mixed
Confidence
MED
Healthcare/Pharmaceuticals
Artificial Intelligence/Software
Medical Devices
Primary Care Services
Elderly Care/Geriatrics
Elderly patients could benefit from improved medication management and reduced adverse drug interactions, but current AI limitations pose safety risks. Healthcare costs may decrease through optimized deprescribing, though implementation delays due to validation needs may slow consumer benefits.
Regulators (FDA, CMS) will likely require rigorous validation protocols before AI-assisted deprescribing tools can be deployed clinically. Healthcare systems may need updated liability frameworks and physician oversight requirements. Potential for new reimbursement models for AI-assisted medication reviews.